NCT00039663View on ClinicalTrials.gov

Endothelial Dysfunction as a Risk Factor in HIV Study

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

October 31, 2005

Conditions
HIV Infections
Interventions
DRUG

Pravastatin

DRUG

Gemfibrozil

DRUG

Rosiglitazone

Trial Locations (1)

20892

National Institutes of Health Clinical Center (CC), Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00039663 - Endothelial Dysfunction as a Risk Factor in HIV Study | Biotech Hunter | Biotech Hunter